Preventing intrathecal administration of vincristine [6]

Medical Journal of Australia

Volumn 181, Issue 8, 2004, Pages 464-

  Gilbar, Peter J ^a   Carrington, Christine V ^a  

^a Soc Hosp Pharmacists of Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VINCRISTINE;

BOLUS INJECTION; DRUG CYTOTOXICITY; DRUG FATALITY; DRUG LABELING; DRUG PACKAGING; DRUG SAFETY; HUMAN; LETTER; MEDICAL ERROR; NEUROTOXICITY; PARALYSIS; RISK ASSESSMENT; STAFF TRAINING; SYRINGE;

EID: 7044241401     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb06394.x     Document Type: Letter

References (5)

1. ABC Television. The 7.30 Report. 2004; 5 May. Hospital mistakes. Available at: www.abc.net.au/7.30/content/2004/s1102214.htm (accessed Sep 2004)
2. Schochet SS, Lampert PW, Earle KM. Neuronal changes induced by intrathecal vincristine sulfate. J Neurophatol Exp Neurol 1968; 27: 645-658.
3. Stefanou A, Dooley M. Simple method to eliminate the risk of inadvertent intrathecal vincristine administration [letter]. J Clin Oncol 2003; 21: 2044-2047.
4. Meggs WJ, Hoffman RS. Fatality resulting from intraventricular vincristine administration. J Toxicol Clin Toxicol 1998; 36: 243-246.
5. Alcaraz A, Rey C, Concha A, Medina A. Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion. J Toxicol Clin Toxicol 2002; 40: 557-561.